Chronic Opioid Therapy and Sleep: An American Academy of Sleep Medicine Position Statement
Author(s) -
Ilene M. Rosen,
R. Nisha Aurora,
Douglas B. Kirsch,
Kelly A. Carden,
Raman K. Malhotra,
Kannan Ramar,
Fariha Abbasi-Feinberg,
David A. Kristo,
Jennifer L. Martin,
Eric J. Olson,
Carol L. Rosen,
James A. Rowley,
Anita V. Shelgikar
Publication year - 2019
Publication title -
journal of clinical sleep medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 92
eISSN - 1550-9397
pISSN - 1550-9389
DOI - 10.5664/jcsm.8062
Subject(s) - medicine , sleep medicine , sleep (system call) , position statement , polysomnography , pain medicine , chronic pain , alternative medicine , psychiatry , physical therapy , sleep disorder , family medicine , insomnia , electroencephalography , anesthesiology , computer science , operating system , pathology
There is a complex relationship among opioids, sleep and daytime function. Patients and medical providers should be aware that chronic opioid therapy can alter sleep architecture and sleep quality as well as contribute to daytime sleepiness. It is also important for medical providers to be cognizant of other adverse effects of chronic opioid use including the impact on respiratory function during sleep. Opioids are associated with several types of sleep-disordered breathing, including sleep-related hypoventilation, central sleep apnea (CSA), and obstructive sleep apnea (OSA). Appropriate screening, diagnostic testing, and treatment of opioid-associated sleep-disordered breathing can improve patients' health and quality of life. Collaboration among medical providers is encouraged to provide high quality, patient-centered care for people who are treated with chronic opioid therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom